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junction: requirement for rapsyn and the
utrophin/dystrophin-associated complex
Abstract
Neuromuscular synapse formation is brought about by a complex bi-directional exchange of information
between the innervating motor neuron and its target skeletal muscle fiber. Agrin, a heparin sulfate
proteoglycan, is released from the motor nerve terminal to activate its muscle-specific kinase (MuSK)
receptor that leads to a second messenger cascade requiring rapsyn to ultimately bring about AChR
clustering in the muscle membrane. Rapsyn performs many functions in skeletal muscle. First, rapsyn
and AChRs co-target to the postsynatic apparatus. Second, rapsyn may self associate to stabilize and
promote AChR clustering. Third, rapsyn is essential for AChR cluster formation. Fourth, rapsyn is
required to transduce the agrin-evoked MuSK phosphorylation signal to AChRs. Finally, rapsyn links
AChRs to the utrophin-associated complex, which appears to be required for AChR stabilization as well
as maturation of the neuromuscular junction. Proteins within the utrophin-associated complex such as
alpha-dystrobrevin and alpha-syntrophin are also important for signaling events that affect
neuromuscular synapse stability and function. Here we review our current understanding of the role of
the postsynaptic-submembrane machinery involving rapsyn and the utrophin-associated complex at the
neuromuscular synapse. In addition we briefly review how these studies of the neuromuscular junction
relate to GABAergic and glycinergic synapses in the CNS.
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Abstract 
Neuromuscular synapse formation is brought about by a complex bi-directional 
exchange of information between the innervating motor neuron and its target skeletal 
muscle fiber.  Agrin, a heparin sulfate proteoglycan, is released from the motor nerve 
terminal to activate its muscle-specific kinase (MuSK) receptor that leads to a second 
messenger cascade requiring rapsyn to ultimately bring about AChR clustering in the 
muscle membrane.  Rapsyn performs many functions in skeletal muscle.  First, rapsyn 
and AChRs co-target to the postsynatic apparatus.  Second, rapsyn may self associate to 
stabilize and promote AChR clustering.  Third, rapsyn is essential for AChR cluster 
formation.  Fourth, rapsyn is required to transduce the agrin-evoked MuSK 
phosphorylation signal to AChRs.  Finally, rapsyn links AChRs to the utrophin-
associated complex, which appears to be required for AChR stabilization as well as 
maturation of the neuromuscular junction.  Proteins within the utrophin-associated 
complex such as α-dystrobrevin and α-syntrophin are also important for signaling 
events that affect neuromuscular synapse stability and function.  Here we review our 
current understanding of the role of the postsynaptic-submembrane machinery involving 
rapsyn and the utrophin-associated complex at the neuromuscular synapse.  In addition 
we briefly review how these studies of the neuromuscular junction relate to GABAergic 
and glycinergic synapses in the CNS. 
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Introduction 
The ultimate goal of a chemical synapse is to provide efficient transmission whenever it 
is required. The most striking specialization that confers this efficiency at the 
neuromuscular junction is the direct apposition of the vesicle release sites (called active 
zones) in the motor nerve terminal with AChR clusters at the tops of junctional folds in 
skeletal muscle.  AChRs are found at densities up to 10,000/μm2 at the synapse 
compared to 10/μm2 in extrajunctional regions (Fertuck and Salpeter 1974). This high 
concentration of AChRs ensures that the nerve can efficiently evoke muscle contraction 
(Gautam et al., 1995; Gautam et al., 1996; DeChiara et al., 1996; Banks et al., 2003).  
Therefore, it is important to know the molecular mechanisms that initiate and maintain 
AChR clusters at the neuromuscular synapse.   
 
One of the initiating signals for AChR cluster formation is the heparin sulfate 
proteoglycan, agrin (McMahan 1990).  Agrin has many isoforms that vary in their 
AChR clustering activity (Burgess et al., 2000; Burgess et al., 2002). As agrin is 
extensively reviewed elsewhere in this issue, it will suffice to say here that the neural 
agrin isoform (called z-agrin in mammals) has the most potent AChR clustering 
activity.  Neural agrin is made by motor neurons, anterogradely transported to the 
synaptic terminal where it is released and activates its muscle specific kinase (MuSK) 
receptor on the postsynaptic membrane (reviewed elsewhere in this issue).  MuSK is a 
tyrosine kinase receptor found in the muscle membrane that is activated upon agrin 
stimulation. MuSK activation leads to a second messenger cascade that ultimately 
induces AChR cluster formation and nucleates the postsynaptic apparatus (DeChiara et 
al., 1996; Apel et al., 1997).  In addition, laminin within the basal lamina  also acts to 
cluster AChRs, but in a α-dystroglycan dependent, MuSK-independent fashion 
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(Sugiyama et al., 1997; Montanaro et al., 1998). Interestingly, the clustering effects of 
agrin and laminin appear additive (Sugiyama et al., 1997; Burkin et al., 1998).  The 
agrin and laminin pathways leading to clustering of AChRs overlap to a significant 
degree intracellularly because both require rapsyn and downstream tyrosine kinases 
(Marangi et al., 2002). 
 
Whether agrin or laminin induces AChR clusters, the formation of all AChR clusters 
requires the receptor-associated protein at the synapse, rapsyn (formerly known as the 
43K protein; Frail et al., 1988; Gautam et al., 1995; Marangi et al., 2002).  Rapsyn is a 
43kD protein originally identified at synapses in the Torpedo electrocyte (Sobel et al., 
1977; Sealock et al., 1984).  Rapsyn is present at the neuromuscular postsynaptic 
membrane in mammals from the initial stages of synapse formation and may associate 
with AChRs in a 1:1 stoichiometry (LaRochelle and Froehner 1986, 1987; Daniels et 
al., 1990; Yoshihara and Hall 1993; Moransard et al., 2003).  In addition, rapsyn 
clusters AChRs when co-expressed in various heterologous cell systems (Froehner et 
al., 1990; Phillips et al., 1991a; Phillips et al., 1991b). Rapsyn null mice have no AChR 
clusters throughout development and lack other postsynaptic proteins such as 
dystroglycan, utrophin and syntrophin (Gautam et al., 1995).  Together these studies 
suggest that rapsyn is essential for anchoring AChR clusters to the subsynaptic 
cytoskeleton. 
 
Here, we focus on the role of rapsyn in AChR cluster formation and possible 
associations with the utrophin-associated complex.  Furthermore, we consider possible 
signaling events that arise from the utrophin-associated complex and how these may 
influence synapse formation at the neuromuscular junction.   
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Rapsyn 
Rapsyn is an amphipathic protein that contains a myristoylated amino terminus 
necessary for membrane targeting (Musil et al., 1988; Fig. 1). The myristoylation 
sequence is followed by eight tetratrichopeptide repeats (TPR) that are necessary for 
rapsyn-self association in heterologous cell systems (Ponting and Phillips 1996; 
Ramarao and Cohen 1998; Ramarao et al., 2001).  The eighth TPR overlaps an α-helical 
amphipathic sequence, predicted to be a coiled-coil structure necessary for binding to 
and clustering AChRs.  The TPR repeats are followed by a carboxy terminal cysteine 
rich zinc finger domain (RING-H2 domain) thought to be necessary for AChR stability 
and linking rapsyn with the utrophin-associated complex (Fig. 1). 
 
Rapsyn and AChR co-target to the postsynaptic apparatus 
Some skeletal muscle nuclei lie underneath the neuromuscular synapse and selectively 
express mRNA encoding postsynaptic proteins such as rapsyn and AChRs in high 
concentrations compared to extrasynaptic muscle nuclei (Burden 1993; Moscoso et al., 
1995; Schaeffer et al., 2001).  Between the nuclei and the synapse is a subsynaptic 
sarcoplasm containing a golgi apparatus and a network of stable microtubules (Jasmin et 
al., 1989; Jasmin et al., 1990; Antony et al., 1995; Jasmin et al., 1995).  Together, 
increased subsynaptic transcription and local trafficking of synaptic molecules may aid 
considerably in concentrating proteins to the neuromuscular junction (Marchand and 
Cartaud 2002).   
 
Rapsyn may target AChR to the sarcolemmal membrane, thereby providing an efficient 
mechanism that delivers high concentrations of AChRs to the synaptic or perisynaptic 
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region.  Rapsyn has a myristoylation site at its N-terminus that is essential for its 
targeting to the plasma membrane (Porter and Froehner 1985; Musil et al., 1988; 
Phillips et al., 1991b; Ramarao and Cohen 1998).  Truncated forms of rapsyn lacking 
the myristoylation site are unable to target to the surface membrane and are found in or 
around the nucleus (Ramarao and Cohen 1998).  Rapsyn is co-targeted with AChR to 
the membrane via the exocytotic pathway on lipid rafts in post-golgi vesicles in 
Torpedo electrocytes and in COS-7 cells (Marchand et al., 2000; Marchand et al., 2002).  
While likely, the requirement for myristoylation of rapsyn for its association with post-
golgi vesicles or lipid rafts has not been fully tested.  In any case, post-golgi vesicles 
containing rapsyn and AChRs appear to be transported upon microtubules to the outer 
membrane in COS-7 cells (Marchand et al., 2000; Marchand et al., 2002).  However, 
rapsyn is not required for expression of AChRs on the surface membrane (Froehner et 
al., 1990; Kopta and Steinbach 1994; Dai et al., 1996; Phillips et al., 1997; Wang et al., 
1999) and AChR intracellular distribution is unchanged upon coexpression with rapsyn 
(Marchand et al., 2002).  Furthermore, only a small proportion (~10%) of rapsyn binds 
to AChR within the cell (such as in post-golgi vesicles) compared to rapsyn binding to 
AChR in the muscle membrane (Moransard et al., 2003).  Thus, while it is clear that the 
myristoylation sequence is necessary for membrane association of rapsyn, it has yet to 
be directly tested whether rapsyn is essential for targeting AChR to the postsynaptic 
apparatus from intracellular vesicles. 
 
On the other hand, AChRs are clearly required for synaptic targeting of rapsyn. In 
mutant myotubes lacking AChRs, agrin does not cause clustering of rapsyn, although 
the amounts of rapsyn are significantly reduced in these cells (LaRochelle et al., 1989, 
Marangi et al., 2001). More importantly, agrin does not induce clustering of rapsyn 
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when AChRs are down regulated by myasthenia gravis-like AChR antibodies in wild-
type myotubes (Marangi et al., 2001).  Upon ectopic injection into muscle fibers in vivo, 
rapsyn alone does not form clusters in the absence of AChRs (Marangi et al., 2001). 
These data indicate an active role of the AChR in clustering of rapsyn in muscle. 
Similarly, in mutant zebrafish lacking AChRs, rapsyn clusters are not observed at the 
neuromuscular junction, demonstrating an in vivo-requirement for AChRs to target 
rapsyn to the synapse (Ono et al., 2001). Taken together, it appears that rapsyn and the 
AChR are co-targeted as a complex through parts of the secretory pathway. In this 
complex, AChR and rapsyn appear mutually important: while AChRs and possibly 
rapsyn ensure synaptic targeting of the complex, rapsyn is necessary for the complex to 
actually form a high-density cluster. 
 
Consistent with co-targeting of rapsyn and AChRs, rapsyn may link AChRs in the 
muscle membrane before they cluster to the neuromuscular junction (Moransard et al., 
2003).  In denervated mouse diaphragms, AChR and rapsyn expression is increased to 
detectable levels in extrasynaptic regions allowing one to test for an association between 
rapsyn and non-clustered AChR (Moransard et al., 2003).  Rapsyn associates with non-
clustered AChRs in these extrasynaptic regions of muscle in vivo and in cultured 
myotubes that lack AChR clusters (Moransard et al., 2003).  In addition, neural-agrin 
increases the amount of rapsyn that associates with surface AChR clusters independent 
of the secretory pathway so that more rapsyn associates with AChRs in synaptic 
(clustered) verses non-synaptic (not clustered) regions of muscle (Moransard et al., 
2003).  The proportion of rapsyn is important for AChR clustering as a small increase in 
rapsyn expression can promote AChR clustering while a large increase can disrupt 
AChR clustering (Yoshihara and Hall 1993; Han et al., 1999).  Agrin may increase the 
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amount of rapsyn that associates with AChRs in the muscle membrane to levels that 
enhance clustering during synapse formation and stabilization (Moransard et al., 2003). 
In summary, rapsyn and AChRs may co-target from the subsynaptic exocytotic 
pathway, while an agrin-induced increase in this interaction at the muscle surface may 
then allow for the targeting from the extrasynaptic muscle membrane to the postsynaptic 
apparatus. 
 
Rapsyn self association (self clustering)  
Rapsyn self-clusters when expressed in heterologous cell systems (Froehner et al., 1990; 
Phillips et al., 1991a; Ramarao and Cohen 1998; Ramarao et al., 2001).  Rapsyn 
constructs containing only TPRs with the N-terminal myristoylation sequence are 
sufficient for clustering rapsyn, but are unable to cluster AChRs when co-expressed in 
HEK293T cells (Ramarao and Cohen 1998).  It is uncertain which TPRs are required 
for self association.  TPRs 1-2, 1-7 and 3-7 promote self association suggesting that 
TPRs 1 and 2 are not essential (Ramarao et al., 2001).  In addition, TPRs 1 or 2 are 
insufficient for rapsyn self-association.  Therefore, both membrane targeting and certain 
TPR combinations are essential for rapsyn self association in heterologous cells.  
 
The significance of rapsyn self-association in vivo is unclear.  The fact that rapsyn can 
self associate in HEK293 cells, oocytes and QT6 cells and recruit MuSK, AChR and 
dystroglycan to a rapsyn scaffold (Froehner et al., 1990; Dai et al., 1996; Gillespie et al., 
1996; Apel et al., 1997) suggests that rapsyn may act to nucleate AChR clusters in 
muscle (Ramarao and Cohen 1998; Ramarao et al., 2001).  However, MuSK clusters are 
found adjacent to nerve terminal endings in rapsyn-deficient mice suggesting that 
MuSK, rather than rapsyn nucleates the postsynaptic apparatus in muscle (Apel et al., 
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1997). In addition, transient overexpression of rapsyn in cultured myotubes does not 
lead to rapsyn self-association even in the presence of agrin (Han et al., 1999).  
Furthermore, rapsyn requires AChRs to form agrin-induced clusters in cultured 
myotubes (Marangi et al., 2001) and to accumulate at the neuromuscular junction (Ono 
et al., 2001), and rapsyn expressed ectopically in mature muscle does not self-aggregate 
(Marangi et al., 2001). Therefore, rapsyn alone does not self-aggregate in muscle, 
implying that inhibition of rapsyn self-association by unidentified molecules may occur 
in muscle.  Perhaps inhibition of rapsyn self-association is reversed in part by 
agrin/MuSK-triggered association of rapsyn with AChRs (Moransard et al., 2003) and 
by MuSK nucleation of the postsynaptic site (Apel et al., 1997), thereby permitting 
rapsyn to self-associate and regulate AChR cluster size and stability.      
 
Mutations in the rapsyn gene have recently been recognized as one reason for a group of 
genetic human diseases at the NMJ, the congenital myasthenic syndromes (Dunne and 
Maselli, 2003; Engel et al., 2002; Engel et al., 2003a; Engel et al., 2003b; Muller et al., 
2003; Ohno et al., 2002; Ohno et al., 2003; Richard et al., 2003). Mutations within the 
coding region of the human rapsyn gene or within the E-box of its promotor lead to 
myasthenic syndrome, with typical symptoms such as reduced ability to move, 
respiratory problems, but, in some cases, also facial malformations (Ohno et al., 2002; 
Ohno et al., 2003). At the neuromuscular junctions of these patients, levels of rapsyn 
and the AChR are reduced, and the mutant synapses have a rather flat postsynaptic 
membrane with a strong reduction in postjunctional folding (Ohno et al., 2002; Ohno et 
al., 2003). Of particular interest are mutations - single amino acid exchanges leading to 
point mutations or truncations – within the N-terminal portion of the rapsyn protein 
encompassing the TPR domains. Of these, N88K, an Asn to Lys change within the third 
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TPR domain, appears to occur most often (Dunne and Maselli, 2003; Muller et al., 
2003; Ohno et al., 2002; Richard et al., 2003). The TPR mutations do not interfere with 
rapsyn self-association when expressed in  HEK cells but do diminish co-clustering of 
the AChR with rapsyn in this system (Ohno et al., 2002). At first sight, this appears to 
contradict mutational domain analysis of rapsyn in transfected cells, showing that the 
TPR domains are essential for rapsyn self-aggregation (Ramarao and Cohen 1998; 
Ramarao et al., 2001). However, since the human mutations are point mutations and not 
targeted truncations, they most likely lead to rapsyn proteins folded in complex and 
aberrant ways hard to predict. This may explain why AChR clustering and not rapsyn 
self-association is affected in these proteins.  
 
Rapsyn clusters muscle AChR 
The demonstration of a direct interaction between rapsyn and AChRs using 
conventional biochemical assays has historically proven to be difficult (Burden et al., 
1983; Froehner 1991; Bezakova and Bloch 1998; Colledge and Froehner 1998).  
Indirect evidence suggests that rapsyn binds to the intracellular loops of all AChR 
subunits in skeletal muscle (Porter and Froehner 1983; Sealock et al., 1984; Bridgman 
et al., 1987; Krikorian and Bloch 1992; Maimone and Merlie 1993; Maimone and Enigk 
1999) from the initial stages of neuromuscular synaptogenesis (Peng and Froehner 
1985; Noakes et al., 1993).  Only recently has rapsyn been shown to specifically co-
precipitate with AChRs (Fuhrer et al., 1999).  Consequently, expression of rapsyn 
variants and AChR subunits in heterologous cell systems has historically proven the 
most often used tool in deciphering the mechanism that underlies rapsyn clustering of 
AChRs.   
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Transient expression of rapsyn and AChR in oocytes (Froehner et al., 1990) and 
HEK293 cells (Phillips et al., 1991a) showed that AChRs cluster only when 
coexpressed with rapsyn and that the AChR clusters are colocalized with rapsyn 
clusters. Rapsyn contains a region toward the carboxy terminus (amino acids 293-331) 
that overlaps TPR8 and is predicted to form an alternative amphipathic α-helical motif, 
or coiled-coil structure (Lupas 1996; Ramarao and Cohen 1998).  A rapsyn mutant 
lacking the coiled-coil domain fails to cluster AChR when coexpressed in HEK293 cells 
(Ramarao and Cohen 1998; Ramarao et al., 2001). Furthermore, the hydrophobic region 
of this coiled-coil domain is necessary for rapsyn to induce AChR clusters (Ramarao et 
al., 2001).  Thus, the ability of rapsyn to target to the cellular membrane and associate 
with AChRs via the coiled-coil domain are both required for AChR cluster formation.  
 
The generation of genetic knockout (mutant) mice shows that rapsyn is necessary for 
AChR clustering in vivo (Gautam et al., 1995).  Rapsyn mutant mice have no AChR 
clusters at any stage of development (Gautam et al., 1995; Lin et al., 2001).  As a result, 
rapsyn mutant mice exhibit severe respiratory failure causing the mice to die only hours 
after birth (Gautam et al., 1995; Banks et al., 2003).  In rapsyn-deficient myotubes, the 
transfection of rapsyn cDNA restores AChR clustering (Han et al., 1999).  Thus, rapsyn 
is essential for AChR cluster formation.  
 
In addition to clustering AChRs, rapsyn also functions to stabilize AChRs in the cell 
membrane.  Co-expression of rapsyn and AChR in COS cells and in QT6 fibroblasts 
slows the metabolic degradation of AChRs from 11 hours to 17-24 hours depending on 
the dose of rapsyn cDNA (Phillips et al., 1997; Wang et al., 1999).  In addition, AChR 
turnover is faster (19 hours) in rapsyn-deficient myotubes compared to heterozygote 
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myotubes (37 hours; Wang et al., 1999).  Therefore, rapsyn is essential for nicotinic 
AChR cluster formation and stabilization in muscle. AChRs, in turn, appear to stabilize 
rapsyn in cultured myotubes. In mutant myotubes lacking AChRs, rapsyn is synthesized 
normally but degraded more rapidly than in wild-type myotubes (Marangi et al., 2001; 
see online supplementary information in this paper). Although secondary effects cannot 
be excluded in these mutant cells, it appears that AChRs stabilize rapsyn in muscle. 
Since rapsyn likewise stabilizes AChRs (see paragraph above), it seems that the 
association of both proteins in a complex ensures optimal stabilization of both rapsyn 
and the AChR. Together with the proposed roles of AChR and rapsyn in mutual sub-
cellular targeting (see previous paragraph), it appears that such complex formation 
between rapsyn and AChRs is a central aspect for rapsyn to achieve optimally its 
function in synaptic clustering of AChRs (Huh and Fuhrer, 2002; Willmann and Fuhrer, 
2002).  
 
Rapsyn links AChR to the utrophin-associated complex  
The C-terminal zinc finger domain and leucine zipper of rapsyn also affects AChR 
clustering (Bezakova and Bloch 1998; Wang et al., 1999).  Injection of small zinc finger 
containing proteins and a GST-Zinc finger fusion protein into muscle myotubes disrupt 
AChR clustering (Bezakova and Bloch 1998). However, this C-terminal region is 
unlikely to bind other rapsyn proteins or to AChRs as coexpression of rapsyn-zinc 
finger and AChR does not affect rapsyn and AChR clustering in HEK293 cells 
(Bezakova and Bloch 1998).  Therefore, the disruption of AChR clustering may be 
brought about by disruption of rapsyn binding to a structural protein such as β-
dystroglycan (Scotland et al., 1993; Bezakova and Bloch 1998; Cartaud et al., 1998; 
Bartoli et al., 2001).  
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In fact, rapsyn links AChRs to the utrophin-associated complex (Apel and Merlie 1995; 
Fuhrer et al., 1999). When co-expressed in heterologous cells, rapsyn co-clusters with 
β-dystroglycan in addition to MuSK and AChRs (Apel et al., 1995; Apel et al., 1997).  
In muscle, β-dystroglycan forms a complex with rapsyn, AChR and utrophin (Fuhrer et 
al., 1999).  Specifically, the C-terminal RING-H2 domain of rapsyn binds to the 
cytoplasmic juxtamembrane region of β-dystroglycan (Cartaud et al., 1998; Bartoli et 
al., 2001).  Thus, rapsyn appears to link AChR to the utrophin-associated complex 
through β-dystroglycan.  Accordingly, in rapsyn-deficient myotubes, association of the 
AChR with β-dystroglycan and utrophin is no longer observed (Fuhrer et al., 1999). 
Rapsyn-mediated linkage of AChRs to the utrophin-associated complex through β-
dystroglycan  is not the only mechanism however, as AChRs can associate with 
utrophin independent of β-dystroglycan in muscle (Fuhrer et al., 1999).  Thus, β-
dystroglycan may be sufficient, but not essential for linking AChR to the utrophin-
associated complex.  
 
Rapsyn-mediated phosphorylation is required to stabilize AChR clusters 
Phosphorylation of proteins at the neuromuscular junction has been implicated in many 
aspects of synapse formation including AChR cluster formation (requiring MuSK), 
AChR transcription (requiring ARIA/Neuregulin and ErbB receptors) and AChR 
desensitization.  This topic is reviewed in depth in other chapters of this volume.  Here 
we focus on the role of rapsyn-dependent phosphorylation and its possible effects on the 
formation of the postsynaptic apparatus.  
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Agrin activation of MuSK leads to a second messenger cascade requiring rapsyn to 
promote AChR clustering.  Central to this second messenger cascade may be a 
phosphorylation signal and a tyrosine kinase cascade downstream of MuSK (Fuhrer et 
al., 1997).  Apart from its kinase activity, the juxtamembrane region of MuSK, 
including a single phosphotyrosine docking site is essential for rapsyn-mediated AChR 
clustering (Herbst and Burden 2000; Herbst et al., 2002).  Rapsyn is required for MuSK 
to cause phosphorylation of the β and δ -subunit of the AChR in C2 myotubes 
(Gillespie et al., 1996; Qu et al., 1996; Apel et al., 1997; Camus et al., 1999; Mittaud et 
al., 2001).  MuSK does not directly phosphorylate the AChR but acts through one or 
several downstream tyrosine kinases, because phosphorylation of MuSK can be 
experimentally separated from phosphorylation of the AChR by pharmacological kinase 
inhibitors (Fuhrer et al., 1997). The tyrosine kinase that actually phosphorylates the 
AChR in response to agrin is still unclear but may be a member(s) of the Src-family 
(Mohamed et al., 2001; however see Smith et al., 2001), because Src-family kinases 
bind to AChRs in myotubes and are activated by agrin (Mittaud et al., 2001). Another 
good candidate for this kinase are Abl kinases, because Abl 1 and/or Abl 2 are required 
in myotubes for agrin-induced AChR clustering (Finn et al., 2003)  Taken together, key 
elements of the agrin signal transduction pathway appear to be MuSK activation, then 
rapsyn-dependent phosphorylation of the AChR β and δ subunits via a downstream 
tyrosine kinase cascade, followed by AChR clustering (Apel et al., 1997; Mittaud et al., 
2001).  Thus, rapsyn is required to transduce the agrin-evoked MuSK phosphorylation 
signal (or autophosphorylation signal; Gillespie et al., 1996) to AChRs (Apel et al., 
1997; Mittaud et al., 2001).  
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Rapsyn phosphorylation of the AChR may not be essential for AChR cluster formation.  
Rapsyn induces phosphorylation of the AChR β and δ subunits when co-expressed and 
co-clustered in fibroblasts (Qu et al., 1996).  Mutation of the tyrosine phosphorylation 
sites on the AChR β subunit does not affect rapsyn-induced clustering in these 
fibroblasts however (Qu et al., 1996).  Furthermore, sites potentially phosphorylated by 
PKA or PKC on rapsyn are not required for AChR cluster formation (Scotland et al., 
1993).  Although in transfected myotubes agrin can induce clustering of mutant AChRs 
lacking tyrosine phosphorylation sites in their β subunits (Meyer and Wallace, 1998), 
the extent of this clustering is clearly reduced (Borges and Ferns, 2001). This shows that 
while phosphorylation of the AChR β subunit does not play a role in rapsyn-induced 
AChR clustering in transfected fibroblasts, it does play a role in AChR clustering 
induced by agrin in muscle.   
 
One downstream effect of rapsyn-mediated tyrosine phosphorylation of AChRs and 
associated cytoskeletal proteins may be to transfer rapsyn from the soluble 
compartments to the cytoskeleton. Rapsyn has low affinity association with Src-family 
kinases, Src, Fyn and Fyk, in transfected QT-6 cells (Mohamed and Swope 1999).  No 
phosphorylation of AChR was seen when it was expressed alone or with Src, Fyk or 
Fyn in  QT-6  cells (Mohamed and Swope 1999).  Upon rapsyn expression alone or with 
Src, Fyk, or Fyn, phosphorylation of AChRs was observed on the β, δ and possibly γ 
subunits (Mohamed and Swope 1999).  Herbimycin A, a protein tyrosine kinase 
inhibitor that also inhibits Src, inhibited this effect (Mohamed and Swope 1999).  Fyn, 
Fyk and Src induce anchoring of the AChR β subunit to the cytoskeleton in a rapsyn-
dependent manner in QT-6 cells (Mohamed and Swope 1999).  In agreement with this, 
Src and Fyn are indeed required for stabilization of AChR clusters that were induced by 
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agrin- or laminin-treatment of myotubes, although these kinases are dispensable for 
formation of the clusters (Smith et al., 2001; Marangi et al., 2002). Finally, 
phosphorylation of AChR β subunits in cultured myotubes, which is induced by agrin 
and requires rapsyn, increases the link of the AChR to the cytoskeleton (Borges and 
Ferns, 2001). Taken together, these findings suggest that rapsyn-mediated 
phosphorylation events, in particular of the AChR β subunit, may be required for 
anchoring and stabilizing AChRs to the subsynaptic cytoskeleton.  
  
The utrophin/dystrophin-associated complex at the neuromuscular 
junction 
Dystrophin resides in the cytoplasmic face of the plasma membrane in skeletal muscle 
and is thought to serve as a molecular link between cytoplasmic γ-actin and the 
surrounding basal lamina, providing mechanical stability to cells (reviewed in Ozawa et 
al., 1995).  This mechanical stability is vital in skeletal muscle, and genetic disruption of 
dystrophin or components of the dystrophin-associated protein (DAP) complex leads to 
muscular dystrophies such as Duchenne and Becker muscular dystrophy (Engel et al., 
2002).  Similarly, a dystrophin homologue called utrophin links the DAP complex to 
actin filaments where AChRs cluster at neuromuscular synapses (Love et al., 1989; 
Tinsley et al., 1992).  The DAP complex can be divided into the dystroglycan and 
sarcoglycan subcomplexes (known as the dystrophin-associated glycoprotein complex) 
and the intracellular syntrophins and dystrobrevins (Madhavan and Jarrett 1995; 
Albrecht and Froehner 2002; Fig. 2).  Nearly all components of this complex are 
important for neuromuscular synapse maturation. 
 
Dystrophin/Utrophin  
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Utrophin is localized with AChRs at the crests of postsynaptic junctional folds whereas 
dystrophin is found with Na+ channels in the troughs of junctional folds (Byers et al., 
1991; Bewick et al., 1992; Peters et al., 1998).  Utrophin promotes the growth of AChR 
clusters in C2 myotubes suggesting that utrophin may function in neuromuscular 
synapse maturation (Phillips et al., 1993).  Utrophin mutant mice are healthy, viable and 
present slight abnormalities in neuromuscular synapse morphology and function 
(Deconinck et al., 1997a; Grady et al., 1997a).  These include a lower density of AChRs 
at the neuromuscular junction and fewer junctional fold openings (Deconinck et al., 
1997a; Grady et al., 1997a), resulting in a depression in miniature endplate current 
amplitudes (Deconinck et al., 1997a).  Dystrophin, β-dystroglycan, dystrobrevin, rapsyn 
and β2-syntrophin are all present at neuromuscular junctions in utrophin mutant mice 
suggesting that utrophin is not essential for localizing these proteins to the 
neuromuscular synapse (Deconinck et al., 1997a; Deconinck et al., 1997b; Grady et al., 
1997a).  Therefore, utrophin appears to be important for maturation of the tertiary 
structure of the postsynaptic apparatus at the neuromuscular junction. 
 
Neuromuscular junctions in mutant mice that lack dystrophin (mdx mice) are generally 
normal but are subdivided into discrete boutons (Grady et al., 1997b).  These 
subdivisions are most likely brought about by muscle degeneration and regeneration.  
Thus, it is difficult to know how dystrophin directly affects the neuromuscular synapse.  
Dystrophin and utrophin do not compensate for each other at neuromuscular synapses as 
in the rest of the muscle.  Nevertheless, utrophin and dystrophin appear to have subtle 
roles in AChR clustering and may participate in maturation of the postsynaptic 
apparatus (Namba and Scheller 1996; Deconinck et al., 1997a; Grady et al., 1997a).   
 
 18
Dystroglycan  
The search for an agrin receptor began after the formulation of the agrin hypothesis, 
which states that agrin is anterogradely transported from the motor neuron cell body and 
is secreted at nerve terminal endings to induce AChR clustering in the adjacent muscle 
membrane (McMahan 1990).  Dystroglycan was one of the initial candidate receptors 
(Bowe et al., 1994; Campanelli et al., 1994; Gee et al., 1994; Sugiyama et al., 1994).  
Agrin binds efficiently to dystroglycan and both are found at neuromuscular junctions 
(Hopf and Hoch 1996).  However, it is now known that agrin promotes AChR clusters 
primarily via a MuSK-dependent mechanism, whereas laminin promotes AChR 
clustering through a dystroglycan-dependent mechanism (Sugiyama et al., 1994; 
Montanaro et al., 1998; Jacobson et al., 2001). The laminin pathway, which may also 
involve α7β1 integrins (Burkin et al., 1998), overlaps with the agrin pathway 
downstream of MuSK, because rapsyn and an as yet unknown downstream kinase(s) are 
required for both agrin- and laminin-induced AChR clustering (Marangi et al., 2002).  
 
Dystroglycan is transcribed from a single gene and is postranslationally processed to 
two forms, namely α- and β-dystroglycan.  Agrin and laminins bind α-dystroglycan 
(Ferns et al., 1993; Campanelli et al., 1994; Fallon and Hall 1994; Gee et al., 1994; 
Sealock and Froehner 1994; Campanelli et al., 1996; Hopf and Hoch 1996; Grady et al., 
2000) so that α-dystroglycan effectively competes with MuSK for agrin (Heathcote et 
al., 2000).  α-Dystroglycan is located on the outside of the muscle and binds to β-
dystroglycan, which spans the muscle membrane. β-Dystroglycan’s localization to the 
neuromuscular junction depends on the presence of rapsyn (Gautam et al., 1995; Fuhrer 
et al., 1999).  β-Dystroglycan, in turn binds to intracellular utrophin at sites of AChR 
clustering or to dystrophin in other regions of the sarcolemma (Chung and Campanelli 
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1999).  Therefore, dystroglycans effectively link the basal lamina to the intracellular 
cytoskeleton in synaptic and non-synaptic regions of muscle (Chung and Campanelli 
1999; Hagiwara and Fallon 2001).  The architecture of this link from the outer basal 
lamina to the intracellular cytoskeleton is dynamic and may be mediated by agrin and 
skeletal muscle activity (Bezakova and Lomo 2001).   
 
Over-expression of dystroglycan disrupts AChR clustering demonstrating its importance 
in synapse formation (Hopf and Hoch 1996; Kahl and Campanelli 2003).  The most 
informative studies of the postsynaptic function of dystroglycans come from chimeric 
mice deficient in both isoforms of dystroglycan (called dystroglycan mutants here) and 
in dystroglycan-deficient myotubes differentiated from embryonic stem cells (called 
dystroglycan mutant myotubes here; Cote et al., 1999; Jacobson et al., 2001; Cote et al., 
2002).  These studies show that dystroglycan acts down stream of rapsyn and agrin.  
Agrin retains its ability to induce AChR clustering through rapsyn in dystroglycan 
mutant myotubes, while laminin is unable to induce AChR clustering.  The AChR 
clusters on dystroglycan mutant myotubes are larger, less dense and dissipate faster in 
response to agrin than in wild-type myotubes.  Therefore, neuromuscular junctions 
without dystroglycan are severely perturbed.  It is possible then, that agrin initiates 
AChR clustering through MuSK and rapsyn followed by the promotion of AChR 
clustering and stabilization by laminin, which acts through a dystroglycan/rapsyn-
dependent mechanism.  In support of such a model is the finding that in cultured 
myotubes that lack AChR clusters (due to downregulation or absence of functional 
AChRs), dystroglycan does not form agrin-induced clusters while MuSK does (Marangi 
et al., 2001). This defines a hierarchy of postsynaptic protein clustering, in which MuSK 
clusters independently of AChRs while aggregation of dystroglycan requires the 
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presence of clustered AChRs. This places aggregation of dystroglycan (and with it 
possibly the action of the laminin-induced clustering pathway) downstream of MuSK-
rapsyn-AChR aggregation. Accordingly, laminin may act via dystroglycan to enhance 
and stabilize cluster formation that was initiated by agrin.  
 
Dystrophin and dystrobrevin localization to the sarcolemma is reduced in most 
myofibres that lack dystroglycan (Cote et al., 1999; Grady et al., 2000; Cote et al., 
2002).  In addition, the restriction of utrophin to the neuromuscular junction is largely 
lost and its expression is reduced in chimeric mice (Cote et al., 1999; Grady et al., 
2000).  Nevertheless, utrophin is present in some neuromuscular junctions deficient in 
dystroglycan suggesting that dystroglycan is not necessary for localizing utrophin to the 
neuromuscular junction (Cote et al., 2002).  In support of this idea, utrophin associates 
with AChR complexes that do not contain α-dystroglycan (Fuhrer et al., 1999).  
Therefore, dystroglycan may be sufficient, but not essential for the localization of 
dystrophin and utrophin (Cote et al., 2002).   
 
Dystroglycan mutant mice present a severe muscular dystrophy-like phenotype (Cote et 
al., 1999) similar to utrophin/dystrophin double mutants (Deconinck et al., 1997b; 
Grady et al., 1997b).  The dystrophic phenotype may be caused by the primary loss of 
dystroglycan in addition to the secondary reduction of dystrophin in the sarcolemma 
(Cote et al., 1999).  In addition utrophin is also reduced at some neuromuscular 
junctions in dystroglycan mutant mice (Cote et al., 1999; Cote et al., 2002).  The lack of 
utrophin and dystrophin may contribute to the disruption of these neuromuscular 
junctions (Cote et al., 1999; Cote et al., 2002).  However, neuromuscular junctions are 
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more severely perturbed in the dystroglycan chimeras than in utrophin/dystrophin 
double mutants (Cote et al., 1999).   
 
Extrajunctional regions of dystroglycan-mutant muscles have normal levels of laminins 
2 (merosin) and 4, perlecan, β1-integrin and agrin (Cote et al., 1999).  On closer 
inspection of neuromuscular junctions however, laminins rarely colocalize with AChR 
clusters (Jacobson et al., 2001).  Thus, the absence of laminin at neuromuscular 
junctions in dystroglycan mutant mice may contribute to the instability of AChR 
clusters in these mutant muscles.  
 
Similar to laminin, perlecan does not colocalize with AChR clusters at dystroglycan 
mutant neuromuscular junctions.  Perlecan is a heparin sulfate proteoglycan located in 
the basal lamina at neuromuscular junctions (Anderson and Fambrough 1983; Bayne et 
al., 1984; Sanes et al., 1986; Iozzo et al., 1994; reviewed in detail in other chapters of 
this volume).  Perlecan is necessary for synaptic localization of acetylcholine esterase 
(AChE), which terminates neurotransmission (Peng et al., 1999; Arikawa-Hirasawa et 
al., 2002).  Accordingly, AChE is missing from neuromuscular junctions that lack 
dystroglycan (Cote et al., 1999; Jacobson et al., 2001; Cote et al., 2002).   
 
Dystroglycan is important for the expression and localization of sarcoglycans in the 
sarcolemma (Cote et al., 2002).  Sarcoglycan deficiencies are central to limb girdle 
muscular dystrophy.  However, α and γ-sarcoglycan mutant mice have qualitatively 
normal neuromuscular junctions (Duclos et al., 1998; Hack et al., 1998).  α-Sarcoglycan 
mutant mice have all isoforms of sarcoglycan displaced from the sarcolemma (Duclos et 
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al., 1998).  Therefore, the absence of sarcoglycans in dystroglycan mutant mice appears 
not to contribute to their abnormal synaptic structure.   
 
In summary, dystroglycan provides a molecular link between the muscle basal lamina 
and cytoskeleton which is necessary for AChR stabilization. In addition, dystroglycan is 
necessary for the localization of perlecan and subsequently AChE. 
 
Syntrophin 
Syntrophins are modular adaptor proteins produced by distinct yet homologous genes 
(Adams et al., 1995).  To date one α, two β, and two γ isoforms have been described 
(Adams et al., 1993; Ahn et al., 1994; Piluso et al., 2000). Syntrophin isoforms differ in 
their tissue distribution and their developmental time course, suggesting distinct 
functions (Adams et al., 1993; Peters et al., 1994; Peters et al., 1997; Kramarcy and 
Sealock 2000).  α-Syntrophin is present at all neuromuscular synapses and in extra-
synaptic regions of the sarcolemma and β1-syntrophin is present throughout the 
sarcolemma in fast muscle fibres at birth and disappears from muscle by 6 weeks of age 
(Kramarcy and Sealock 2000).  β2-syntrophin is first expressed at all neuromuscular 
synapses from postnatal day 6 (Kramarcy and Sealock 2000).  The localization of γ-
syntrophins to the neuromuscular junction has yet to be extensively investigated; 
however, initial studies suggest that γ2 syntrophin is located at the neuromuscular 
junction (A. Alessi, unpublished data).  Thus α, β1, β2 and γ2-syntrophin isoforms may 
have distinct roles at neuromuscular synapses. 
 
Syntrophins are yet to be directly linked to muscular dystrophies like those stemming 
from mutations in dystrophin and sarcoglycan complexes (Ozawa et al., 1995).  
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However their ability to bind diverse signalling molecules to the neural plasmalemma 
and skeletal muscle sarcolemma underlie their importance. Each syntrophin isoform has 
four domains; a PDZ domain, two pleckstrin homology domains and a syntrophin 
unique COOH terminus (Adams et al., 1995).  Syntrophins bind to dystrophin, utrophin 
and dystrobrevin at two neighbouring but distinct sites.  Both the PH2 and the SU 
domains of syntrophin are required for their binding to these proteins (Ahn and Kunkel 
1995; Kachinsky et al., 1999).    The PDZ domain of α-syntrophin binds neuronal nitric 
oxide synthase (nNOS; Brenman et al., 1996; Kameya et al., 1999) and sodium channels 
(NaCh; Gee et al., 1998; Schultz et al., 1998; Adams et al., 2000).  The pleckstrin 
homology domains bind phosphatydilinositol 4,5 biphosphate (Chockalingam et al., 
1999).  Syntrophins also bind calmodulin in two distinct regions, one dependent on 
calcium concentration and one independent of calcium concentration (Iwata et al., 
1998). Syntrophins bind Grb2, the growth factor receptor bound adapter protein (Oak et 
al., 2001) in addition to erbB4 (Garcia et al., 2000), a signalling protein implicated in 
promoting transcription from sub-synaptic nuclei in skeletal muscle (Jo et al., 1995).  
Stress-activated protein kinase (SAPK3; also known as ERK6 and p38γ) a member of 
the mitogen activated protein kinase family binds α-syntrophin at the neuromuscular 
junction, and when activated, phosphorylates a site just downstream of the PDZ domain 
(Hasegawa et al., 1999).  Aquaporin 4 localization to the muscle sarcolemma also 
requires α-syntrophin (Adams et al., 2001; Neely et al., 2001).  β2-Syntrophin localizes 
microtubule-associated serine/threonine kinase (MAST) to the neuromuscular junction 
(Lumeng et al., 1999).  Therefore, syntrophins bind a diverse range of signalling 
molecules to the neuromuscular junction. 
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Genetically modified mice that lack α-syntrophin have immature synapses with shallow 
gutters and patchy, abnormally distributed AChRs that radiate out from the borders of 
the cluster in finger-like projections (Adams et al., 2000; Fig. 3).  The expression of 
AChRs and AChE is reduced at α-syntrophin mutant neuromuscular junctions; nNOS is 
absent from both the sarcolemma and the postsynaptic membrane.  Most surprising is 
that utrophin is absent from neuromuscular synapses in α-syntrophin mutant mice 
(Adams et al., 2000).  The absence of utrophin may contribute to the altered tertiary 
structure of the postsynaptic apparatus in α-syntrophin mutants (Deconinck et al., 
1997a; Grady et al., 1997a; Adams et al., 2000).  It has yet to be tested whether other 
syntrophin isoforms compensate for the absence of α-syntrophin at neuromuscular 
synapses in the mutant mice.  For instance, β1-syntrophin expression is increased in fast 
fibers in α-syntrophin mutant mice (Adams et al., 2000).  Therefore, it is possible that 
syntrophins are essential for localizing many signalling events emanating from and 
regulating the neuromuscular junction. 
 
Dystrobrevin 
Five isoforms of α-dystrobrevin have been described (Blake et al., 1996; Sadoulet-
Puccio et al., 1996; Peters et al., 1998); α−dystrobrevin-1, -2 and –3 are expressed in 
skeletal muscle (Nawrotzki et al., 1998; Peters et al., 1998; Holzfeind et al., 1999; 
Newey et al., 2001).  α-Dystrobrevin 1 is located predominantly at neuromuscular 
synapses (at least in some muscle types) whereas α-dystrobrevin 2 is located on both 
the synaptic and extrasynaptic sarcolemma (Peters et al., 1998; Newey et al., 2001).  α-
Dystrobrevin 3 has yet to be studied in detail. The contribution of α-dystrobrevin to 
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neuromuscular synapse formation has been studied in genetically-modified mice that 
lack α-dystrobrevin.  
 
α-Dystrobrevin mutant mice exhibit a dystrophic phenotype that is somewhat milder 
than in the mdx mice (Grady et al., 1999).  α-Dystrobrevin is not necessary for synapse 
formation, but is required for AChR cluster maintenance (Grady et al., 2000).  AChR 
clusters in α-dystrobrevin mutant mice have patchy, granular distribution that radiate 
from the postsynaptic borders, very similar to that seen in α-syntrophin null mice 
(Adams et al., 2000; Grady et al., 2000; Fig 3).  In addition, AChR clusters are less 
stable and AChRs themselves turn over more rapidly in α-dystrobrevin mutant muscle 
compared to their wild-type counterparts (Grady et al., 2000; Akaaboune et al., 2002).  
Furthermore, α-dystrobrevin mutant neuromuscular junctions have fewer junctional 
folds and altered junctional fold architecture, again similar to junctions lacking α-
syntrophin.  Since synaptic α-syntrophin levels are reduced in α-dystrobrevin null mice, 
it seems likely that at least some of the synaptic aberrations seen in the α-dystrobrevin 
null mice are the result of α-syntrophin loss. 
 
Transgenic rescue experiments with α-dystrobrevin 1 or α-dystrobrevin 2 in the α-
dystrobrevin mutant mice suggest distinct roles for these two isoforms at the synapse 
(Grady et al., 2003).  Both isoforms partially rescued the AChR cluster phenotype with 
α-dystrobrevin 1 being more effective than α-dystrobrevin 2 (Grady et al., 2003).  
These results are in accordance with their localization, with α-dystrobrevin 1 being 
localized primarily at the crests of junctional folds with AChR whereas α-dystrobrevin 
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2 is localized at the troughs of junctional folds (Peters et al., 1998). Thus, α-
dystrobrevin 1 is more important than α-dystrobrevin 2 for AChR cluster stability.   
 
The most striking observation for the dystrobrevin mutant mice is that they present a 
dystrophic phenotype and disrupted AChR clusters without disruption of the remaining 
components of the DAP complex.  The localization of laminin2, β-dystroglycan, α-
sarcoglycan, dystrophin and utrophin in α-dystrobrevin mutant mice is unchanged 
(Grady et al., 1999; see below and Grady et al., 2000).  Thus, dystrobrevin may contain 
and/or affect signalling events that are important for muscle viability and AChR 
stability.  The first implicated signalling component was nNOS (Grady et al., 1999).  
Considering that α-dystrobrevin binds to α-syntrophin, which in turn binds to nNOS, it 
was surprising to note that nNOS was absent from the sarcolemma and neuromuscular 
junction, even though α-syntrophin localization was largely unaffected (Grady et al., 
1999).  However, more recent studies of the α-dystrobrevin mutant suggest that nNOS 
is not absent from the sarcolemma, but is reduced along with α1-syntrophin and β2-
syntrophin (Grady et al., 2000).  Our own results are consistent with the latter result: 
nNOS and α-syntrophin are similarly reduced in the α-dystrobrevin mutant mice (Fig. 
4).  Therefore, the reduction of α-syntrophin and nNOS may contribute to the 
neuromuscular phenotype in α-dystrobrevin mutant mice (Adams et al., 2000; Grady et 
al., 2000).  However, α-syntrophin mutant mice that lack nNOS in the sarcolemma do 
not present a dystrophic phenotype (Adams et al., 2000), suggesting a reduction of 
nNOS in the sarcolemma most likely does not account for the dystrophic phenotype of 
α-dystrobrevin mutant mice.  Therefore, the dystrophic phenotype and possibly the 
altered postsynaptic phenotype in α-dystrobrevin mutant mice most likely involve 
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additional signalling components.  For instance, phosphorylation of α-dystrobrevin 1 is 
suggested to contribute to the postsynaptic phenotype in α-dystrobrevin mutant mice 
(Grady et al., 2003).  Since Src and Fyn stabilize AChR clusters in cultured myotubes 
(Smith et al., 2001; Marangi et al., 2002), it is possible that the action of α-dystrobrevin 
1 in cluster maintenance involves its phosphorylation by and/or interaction with Src and 
Fyn. 
 
Relevance to glycinergic and GABAergic synapses in the CNS 
The study of neuromuscular synapses provides a great number of insights into the 
formation of CNS synapses.  Perhaps the most pertinent to this review are glycinergic 
and GABAergic synapses.  Glycine receptors are clustered by gephyrin, a tubular 
binding protein that links the glycine receptor β-subunit to the subsynaptic cytoskeleton 
(much like rapsyn for AChR clusters at neuromuscular synapses; Kirsch et al., 1993; 
Kirsch and Betz 1995; Kirsch et al., 1995; Feng et al., 1998; Kirsch and Betz 1998; 
Fuhrmann et al., 2002).  Accordingly, glycine receptor clusters are absent in gephyrin 
mutant mice (Feng et al., 1998).  As yet, no evidence for the direct binding of gephyrin 
to GABAA receptors has been found. Despite this, GABAA receptor clusters are 
severely perturbed or absent in gephyrin mutant mice (Kneussel et al., 1999).  GABAA 
receptor α2 and γ2 subunits traffic to the membrane but are quickly internalized into 
vesicles that resemble microclusters (Kneussel et al., 1999).  Both the α3 and β2/3 
GABAA receptor subunits are clustered, but to a lesser degree (Kneussel et al., 2001).  
The α3 and β2/3 GABAA receptor clusters colocalize to a presynaptic apparatus and 
presumably form functional synapses (Kneussel et al., 2001).  The GABAA receptor α1 
and α5 subunits appear unaffected by the loss of gephyrin (Kneussel et al., 2001).  The 
loss of gephyrin is specific for GABA and glycine receptors as there is little to no 
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change in NMDA, postsynaptic density protein 95 (PSD95), glutamate receptor or PDZ 
clustering in gephyrin-deficient mice (Feng et al., 1998; Kneussel et al., 2001).  
Therefore, gephyrin is essential for clustering glycine and most GABAA receptors at the 
postsynaptic apparatus.  Gephyrin-deficient mice also lack molybdenum cofactor 
biosynthesis, but this does not appear to be required for the CNS phenotype of these 
mice (Grosskreutz et al., 2003).  Gephyrin mutant mice, similar to rapsyn mutant mice 
die within 24 hours after birth, suggesting that the loss of the precise apposition between 
both pre and postsynaptic elements of the synapse results in inefficient 
neurotransmission much like it does in rapsyn, agrin and MuSK mutant mice (Noakes et 
al., 1995; DeChiara et al., 1996; Gautam et al., 1996; Feng et al., 1998; Banks et al., 
2003). 
 
Another interesting parallel between the neuromuscular junction and inhibitory 
GABAergic synapses is the mutual need of neurotransmitter receptor and its scaffolding 
protein to form clusters at the synapse.  As mentioned above, many GABAA receptors 
including γ2 require gephyrin to form synaptic clusters (Kneussel et al., 1999).  In turn, 
synaptic clusters of gephyrin are absent in mice deficient for the GABAA receptor γ2, 
synaptic clusters of gephyrin are absent (Essrich et al., 1998).  This shows that both γ2-
containing GABAA receptors and gephyrin are mutually required to form synaptic 
aggregates. In a similar fashion, AChR clusters are absent in rapsyn-deficient mice 
(Gautam et al., 1995); rapsyn in turn does not form agrin-induced clusters in myotubes 
in which AChRs are missing (Marangi et al., 2001) and rapsyn does not form synaptic 
clusters in zebrafish that lack AChRs (Ono et al., 2001).  This mutual requirement of 
receptor and scaffolding protein probably originates from their association and 
stabilization in a complex and appears to be specific for inhibitory synapses and the 
 29
NMJ.  At nascent glutamatergic synapses, in vitro time-course studies have revealed 
that scaffolding proteins such as PSD95 accumulate before glutamate receptors do, 
suggesting that PSD95 aggregation occurs rather independently of its interacting 
receptor (Friedman et al., 2000). 
 
Finally, similar to the neuromuscular junction, a subset of GABAergic synapses has a 
dystrophin-associated complex.  Dystrophin, α-dystroglycan, β-dystroglycan and an 
antibody that recognizes α1, β1 and β2 syntrophins colocalize with glutamic acid 
decarboxylase (GAD), a marker for presynaptic inhibitory terminals (Brunig et al., 
2002).  It is not known which syntrophin isoforms localize to GABAergic terminals.  α-
Dystroglycan, β-dystroglycan and dystrophin colocalize with GABAergic synapses 
containing GABAA receptor α1, α2, and γ2 subunits and gephyrin (Brunig et al., 2002; 
Levi et al., 2002).  β-Dystrobrevin is also found in postsynaptic densities which may 
include GABAergic terminals (Blake et al., 1999).  In contrast to neuromuscular 
synapses, utrophin is not located at synapses in the CNS (Knuesel et al., 2001).  The 
function of the dystrophin-associated complex at a subset of GABAergic synapses is 
still unknown.  The dystrophin-associated complex does not appear to be necessary for 
GABAergic synapse formation, but may be required for GABAergic synapse 
stabilization like for the neuromuscular junction (Knuesel et al., 1999; Levi et al., 2002).  
For this reason the dystrophin-associated complex at CNS synapses may be important 
for synaptic plasticity (Vaillend et al., 1998; Moore et al., 2002; Vaillend and Billard 
2002).   
 
Conclusion 
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Rapsyn has many essential roles in neuromuscular synapse formation including AChR 
clustering, sequestering AChR to the postsynaptic apparatus and linking AChR to the 
subsynaptic cytoskeleton.  Various studies show that the subsynaptic cytoskeleton 
including utrophin, dystrobrevin, dystroglycans and syntrophins are important for 
neuromuscular synapse stabilization, maturation and function.  Overall, it is difficult to 
identify a particular role of α-dystrobrevin, dystroglycan or syntrophin alone to 
neuromuscular synapse stability, since all mutant mice lack additional molecules that 
may contribute to their phenotype.  For example, α-dystrobrevin mutant mice have 
reduced syntrophin in the sarcolemma and dystroglycan mutant mice have reduced 
laminin, utrophin, dystrophin, perlecan and AChE at the neuromuscular junction. 
Finally, syntrophin mutant mice have no utrophin and reduced AChR and AChE 
expression at the neuromuscular synapse.  Nevertheless, it is clear from these 
genetically-modified mice that the utrophin associated-complex contains structural and 
signaling components necessary for maturation and stabilization of the neuromuscular 
postsynaptic apparatus.  It will be important to next find how signaling events that arise 
from the submembrane machinery affect neuromuscular synapse formation.  This, in 
turn, may provide information pertinent to the role of the dystrophin-associated complex 
within the CNS. 
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Figure captions 
 
Figure 1.  Domains of rapsyn.  Rapsyn performs four primary functions at the 
postsynaptic apparatus.  Rapsyn targets to the membrane with a myristoylation 
site (MYR).  In addition, rapsyn self-associates via more than one 
tetratricopeptide (TPR) repeat.  Rapsyn interacts with AChRs with a coiled-coil 
motif that overlaps TPR8.  Finally, a zinc ring finger (RING) and possibly 
phosphorylation sites (P) are important for association of rapsyn with other 
postsynaptic cytoskeletal proteins. 
  
Figure 2.  A model of the postsynaptic apparatus.  Agrin activates its muscle-specific 
kinase receptor (MuSK) possibly with MASC (myotube associated specific 
component) to nucleate the postsynaptic apparatus.  MuSK induces AChR 
clustering through rapsyn. It has been proposed that MuSK binding to rapsyn 
could require a rapsyn-associated transmembrane linker (RATL; Apel et al., 
1997).  While MuSK nucleates the postsynaptic apparatus, laminins may also 
induce AChR clustering through α-dystroglycan, β-dystroglycan and rapsyn.  A 
MuSK/rapsyn/AChR complex may bind to a α/β-dystroglycan/rapsyn/AChR 
complex through laminins or by rapsyn/rapsyn interactions (possible rapsyn self-
associations left out of figure for clarity, but would theoretically occur in the 
depth of the page).  α-Dystroglycan binds perlecan, which is necessary for 
localization of AChE.  β-Dystroglycan binds to rapsyn, dystrophin/utrophin, and 
ultimately α-dystrobrevins, syntrophins and the actin cyotskeleton.  Syntrophin 
localizes many signaling molecules to the neuromuscular junction including 
neuronal nitric oxide synthase (nNOS), sodium channels (NaCh), ErbB4 and 
MAST (mitogen activated serine/threonine kinase).   
 
Figure 3.  Selected neuromuscular junctions in A) wildtype, B) α-syntrophin mutant, 
and C) α-dystrobrevin mutant mice.  Muscles were stained with α-bungarotoxin 
(Molecular Probes, Inc., Eugene, OR, USA).  Note that parts of both α-
syntrophin and α-dystrobrevin mutant neuromuscular junctions present a frayed 
appearance.    
 
Figure 4.  Localization of nNOS (green; labelled with antibody; Diasorin Inc.) and 
AChRs (red; labeled with α-bungarotoxin; Molecular Probes, Inc., Eugene, OR, 
USA) at neuromuscular synapses in α-syntrophin mutant and α-dystrobrevin 
mutant mice.  Note that nNOS is absent from the postsynaptic membrane in α-
syntrophin mutant mice but present at reduced levels at the neuromuscular 
synapses in α-dystrobrevin mutant mice. 
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